IO Biotech Announces Phase 3 Results for Cylembio® + KEYTRUDA® in Advanced Melanoma
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT) today announces topline results from the pivotal Phase…
Blog - Melanoma360
08/11/2025
IO Biotech Announces Phase 3 Results for Cylembio® + KEYTRUDA® in Advanced Melanoma
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT) today announces topline results from the pivotal Phase…
|
|
07/25/2025
The FDA Said No — Now We Need Your Voice
Dear Friends, A recent FDA decision denied approval of a promising new treatment called RP1 for advanced melanoma—one that showed…
|
|
07/18/2025
Understanding Tumor Genetics and Melanoma: A Recap of Our Latest Webinar
In the age of precision medicine, understanding the genetics of a tumor—not just a person’s inherited DNA—is playing a critical…
|
07/01/2025
The Cost of Sunscreen May Be Costing Lives
Does Price Influence Sunscreen Use? A Closer Look at the Data The cost of sunscreen could be undermining proper usage,…
07/01/2025
A Conversation with Dr. Rena Szabo, PsyD on Empowering Patients
If you or a loved one is facing melanoma or any form of cancer, you know it’s not just a…
|
06/18/2025
Empowering Women in Melanoma: A Look Inside the Women in Melanoma Initiative
In 2016, the late Valerie Guild—founder and then-president of AIM at Melanoma—attended a melanoma conference and noticed something striking: While…
06/18/2025
Melanoma News and Highlights You Don’t Want to Miss
We know staying informed about melanoma research and treatments is important to you. That’s why we’ve put together some of…
|
06/10/2025
Coping with Cancer: DBT Skills for Emotional Resilience
In this enlightening episode, we are joined by Elizabeth Cohn Stuntz, LCSW, a cancer survivor and expert in emotional well-being,…
|
06/06/2025
May in Review: A Marathon Month of Melanoma Awareness, Education, and Community
By Sam Guild, President, AIM at Melanoma Foundation Wow! May truly felt like running a marathon—and crossing the finish line…
|
06/06/2025
AIM at Melanoma’s 4th Annual Evening in Memory of Valerie Guild
On Saturday, May 31st, AIM supporters, including many influential figures in the melanoma community, gathered for AIM at Melanoma’s 4th…
|
Recent Posts
Oct. 07, 2025
I’ve Failed First-Line Therapy – Now What?
Sep. 09, 2025
Caring Through Loss: A Conversation on Bereavement
Sep. 05, 2025
Advocating for Patients: Letter to the FDA on RP1 Treatment Access
Sep. 04, 2025
Hope on the Horizon: Clinical Trials & Progress in Ocular/Uveal Melanoma
Aug. 26, 2025